Brief: Lidds Licensee Jiangxi Puheng Pharma Prepares For Phase III Trial In China

Lidds AB

07/11/2019 08:46

Nov 7 (Reuters) - Lidds AB  LIDDS.ST :
    * REG-LIDDS LICENSEE JIANGXI PUHENG PHARMA PREPARES FOR
PHASE III
TRIAL IN CHINA
    * INITIATED DISCUSSIONS WITH CHINESE MEDICAL AUTHORITY,
CFDA.
    * PHASE III CLINICAL TRIAL WILL BE CONDUCTED IN UROLOGY
CLINICS IN
CHINA AND WILL BE FULLY FINANCED BY JIANGXI PUHENG PHARMA

Source text for Eikon:  ID:nGNE7g1Kdg 
Further company coverage:  LIDDS.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))